RxSight RXST
NASDAQ RXST
$6.07 -0.09 (-1.54%)
At close: Aug 20, 2026 · 11:16 AM UTC

RxSight (RXST) Other Operating Expenses (2020 - 2026)

RxSight's (RXST) quarterly Other Operating Expenses came in at $7000.0 in Q4 2020.

RxSight (RXST) Other Operating Expenses (2020 - 2026) Analysis & Trends

RxSight (RXST) has 1 years of Other Operating Expenses data on file, last reported at $7000.0 in Q4 2020.

  • Quarterly Other Operating Expenses changed N/A year-over-year to $7000.0 in Q4 2020, while the trailing twelve-month figure through Sep 2021 was $7000.0 (changed N/A YoY) and the FY2020 annual result came in at $7000.0, changed N/A from the prior year.
  • Other Operating Expenses was little changed at $7000.0 in Q4 2020.
  • In the past five years, Other Operating Expenses ranged from a high of $7000.0 in Q4 2020 to a low of $7000.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn
10 RxSight 251.23 Mn -153.02 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 7.86 Mn
Jun 30, 2025 8.45 Mn
Dec 31, 2020 7,000.00